Opioid effects on 45Ca2+ uptake and glutamate release in rat cerebral cortex in primary culture

Journal of Neurochemistry

Volumn 68, Issue 2, 1997, Pages 517-524

  Vlaskovska, Mila ^a   Schramm, Michael ^a,d   Nylander, Ingrid ^a   Kasakov, Lubomir ^a   You, Zhi Bing ^a   Herrera Marschitz, Mario ^b   Terenius, Lars ^a,c  

^a Exp Alcohol Drug Addict Res Sect ^*  (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

45Ca2+ uptake; Dynorphin peptides; Glutamate release; Naloxone; Opiate agonists; Primary culture; Rat cerebral cortex

Indexed keywords

CALCIUM ION; GLUTAMIC ACID; OPIATE DERIVATIVE; AMINO ACID RECEPTOR STIMULATING AGENT; CALCIUM; DYNORPHIN; MORPHINE; N METHYLASPARTIC ACID; NALOXONE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST; OLIGOPEPTIDE; OPIATE RECEPTOR; POTASSIUM;

AMINO ACID TRANSPORT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CALCIUM TRANSPORT; DEPOLARIZATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CELL CULTURE; CELL MEMBRANE POTENTIAL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; FEMALE; FETUS; HOMEOSTASIS; METABOLISM; NEWBORN; PREGNANCY; SPRAGUE DAWLEY RAT; TRANSPORT AT THE CELLULAR LEVEL;

ANALGESICS, OPIOID; ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL TRANSPORT; CALCIUM RADIOISOTOPES; CELLS, CULTURED; CEREBRAL CORTEX; DYNORPHINS; EXCITATORY AMINO ACID AGONISTS; FEMALE; FETUS; GLUTAMIC ACID; HOMEOSTASIS; MEMBRANE POTENTIALS; MORPHINE; N-METHYLASPARTATE; NALOXONE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; POTASSIUM; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID;

EID: 0030614594     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68020517.x     Document Type: Article

References (42)

1. Aghajanian G. K., Kogan J. H., and Moghaddam B. (1994) Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study. Brain Res. 636, 126-130.
2. Alho H., Ferrarese C., Vicini S., and Vaccarino F. (1988) Subsets of GABAergic neurons in dissociated cell cultures of neonatal rat cerebral cortex show co-localization with specific modulator peptides. Brain Res. 467, 193-204.
3. Bergström L., Christensson I., Folkesson R., Stenström B., and Terenius L. (1983) An ion exchange chromatography and radioimmunoassay procedure for measuring opioid peptides and substance P. Life Sci. 33, 1613-1619.
4. Bradford M. M. (1976) A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principal of protein-dye binding. Anal. Biochem. 72, 248-254.
5. Bramham C. R. (1992) Opioid receptor dependent long-term potentiation: peptidergic regulation of synaptic plasticity in the hippocampus. Neurochem. Int. 20, 441-455.
6. Carter B. D. and Medzihradsky F. (1993) Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells. Mol. Pharmacol. 43, 465-473.
7. Chavkin C., Bakhit C., Weber E., and Bloom F. E. (1983) Relative contents and concomitant release of prodynorphin/neoendorphin-derived peptides in rat hippocampus. Proc. Natl. Acad. Sci. USA 80, 7669-7673.
8. Christensson-Nylander N. I., Nyberg F., Ragnarsson U., and Terenius L. (1985) A general procedure for analysis of proenkephalin B derived opioid peptides. Regul. Pept. 11, 65-76.
9. Conner-Kerr T. A., Simmons D. R., Peterson G. M., and Terrian D. M. (1993) Evidence for the corelease of dynorphin and glutamate from rat hippocampal mossy fiber terminals. J. Neurochem. 61, 627-636.
10. Derrick B. E., Rodriguez S. B., Lieberman D. N., and Martinez J. S. Jr. (1992) Mu opioid receptors are associated with the induction of hippocampal mossy fiber long-term potentiation. J. Pharmacol. Exp. Ther. 263, 725-733.
11. 45Ca uptake and toxicity mediated by the N-methyl-D-aspartate receptor: the effect of metal binding agents and transition metal ions. J. Neurochem. 61, 518-525.
12. Eimerl S. and Schramm M. (1994) The quantity of calcium that appears to induce neuronal death. J. Neurochem. 62, 1223-1226.
13. G-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain 56, 69-75.
14. 2+ channels. Neuroscience 54, 401-407.
15. Gannon R. L. and Terrian D. M. (1991) U-50,488H inhibits dynorphin and glutamate release from guinea pig hippocampal mossy fiber terminals. Brain Res. 548, 242-247.
16. Ghosh A., Ginty D. D., Bading H., and Greenberg M. E. (1994) Calcium regulation of gene expression in neuronal cells. J. Neurobiol. 25, 294-303.
17. ++ uptake. J. Pharmacol. Exp. Ther. 209, 132-136.
18. Hansson E. and Rönnbäck L. (1989) Primary cultures of astroglia and neurons from different brain regions, in A Dissection and Tissue Culture Manual of the Nervous System (Shahar A., de Vellis J., Vernadakis A., and Haber B., eds). pp. 92-104. Alan R. Liss, New York.
19. Hayward N. J., McKnight A. T., and Woodruff G. N. (1993) Neuroprotective effect of the kappa-agonist enadoline (CI-977) in rat models of focal cerebral ischemia. Eur. J. Neurosci. 5, 961-967.
20. He X.-P., Lee P. H. K., Pennypacker K. R., Tuominen R. K., Mar E.-C., Thai L., and Hong J.-S. (1992) Characterization of dynorphin-containing neurons on dissociated dentate gyrus cell cultures. Brain Res. 594, 91-98.
21. Herrera-Marschitz M., Meana J. J., O'Connor W. T., Goiny M., Reid M. S., and Ungerstedt U. (1992) Neuronal dependence of extracellular dopamine, acetylcholine, glutamate, aspartate and gamma-aminobutyric acid (GABA) measured simultaneously from rat neostriatum using in vivo microdialysis: reciprocal interactions. Amino Acids 2, 157-179.
22. Herrera-Marschitz M., You Z.-B., Goiny M., Meana J. J., Silveira R., Godukhin O. V., Chen Y., Espinoza S., Pettersson E., Loidl C. F., Lubec G., Andersson K., Nylander I., Terenius L., and Ungerstedt U. (1996) On the origin of extracellular glutamate levels monitored in the basal ganglia of the rat by in vivo microdialysis. J. Neurochem. 66, 1726-1735.
23. Hill M. P. and Brotchie J. M. (1995) Modulation of glutamate release by a κ-opioid receptor agonist in rodent and primate striaturn. Eur. J. Pharmacol. 281, R1-R2.
24. Hou Y.-N., Vlaskovska M., Cebers G., Kasakov L., Liljequist S., and Terenius L. (1996) A μ-receptor opioid agonist induces AP-1 and NF-κB transcription factor activity in primary culture of rat cortical neurons. Neurosci. Lett. 212, 159-162.
25. Jhamandas K. H., Marsala M., Ibuki T., and Yaksh T. L. (1996) Spinal amino acid release and precipitated withdrawal in rats chronically infused with spinal morphine. J. Neurosci. 16, 2758-2766.
26. Kingsbury A., Gallo V., and Balazs R. (1988) Stimulus-coupled release of amino acids from cerebellar granule cells in culture. Brain Res. 448, 46-52.
27. Little H. J. (1995) The role of calcium channels in drug dependence. Drug Alcohol Depend. 38, 173-194.
28. McGinty J. F., Henriksen S. J., Goldstein A., Terenius L., and Bloom F. E. (1982) Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicity. Proc. Natl. Acad. Sci. USA 31, 1797-1800.
29. McMillian M. K., Mullis S. B., Wu G.-C., Hudson P. M., Pennypacker K. R., and Hong J.-S. (1994) Regulation of tyrosine hydroxylase in olfactory bulb cultures: selective inhibition of depolarization-induced increase by endogenous opioids. Brain Res. 658, 105-111.
30. Murphy E. J. and Horrocks L. A. (1993) Mechanisms of hypoxic and ischemic injury. Use of cell culture models. Mol. Chem. Neuropathol 19, 95-105.
31. 2+ transients in astrocytes. Neuroscience 54, 605-614.
32. Nylander I., Vlaskovska M., and Terenius L. (1995) Brain dynorphin and enkephalin systems in Fischer and Lewis rats: effects of morphine tolerance and withdrawal. Brain Res. 683, 25-35.
33. Terrian D. M., Hernandez P. G., Rea M. A., and Peters R. I. (1989) ATP release, adenosine formation, and modulation of dynorphin and glutamic acid release by adenosine analogues in rat hippocampal mossy fiber synaptosomes. J. Neurochem. 53, 1390-1399.
34. Tiseo P. J. and Inturrisi C. E. (1993) Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614. J. Pharmacol. Exp. Ther. 264, 1090-1096.
35. 2+ channel blocker, on naloxone-induced glutamate levels in the locus coeruleus of opioid-dependent rats. Brain Res. 722, 212-216.
36. Tokuyama S., Wakabayashi H., and Ho I. K. (1996) Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome. Eur. J. Pharmacol. 295, 123-129.
37. Trujillo K. A. and Akil H. (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251, 85-87.
38. Wagner J. J., Terman G. W., and Chavkin C. (1993) Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature 363, 451-454.
39. Weisskopf M. G., Zalutsky R. A., and Nicoll R. A. (1993) The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature 362, 423-427.
40. Welch S. P. and Olson K. G. (1991) Opiate tolerance-induced modulation of free intracellular calcium in synaptosomes. Life Sci. 48, 1853-1861.
41. Woodburn V. L., Hayward N. J., Poat J. A., Woodruff G. N., and Hughes J. (1993) The effect of dizocilpine and enadoline on immediate early gene expression in the gerbil global ischaemia. Neuropharmacology 32, 1047-1050.
42. 45Ca into rat cortical synaptosomes by inhibiting N-but not L-type calcium channels. Neuropharmacology 29, 439-444.